Disposable medical device sensors market to reach $16.42 billion by 2030

The disposable medical devices sensors market reached $9.65 billion in 2025 and is projected to hit $16.42 billion by 2030, according to The Business Research Company. Growth is being driven by chronic disease monitoring, telehealth expansion and wider adoption of single-use sensors across healthcare settings.

Why it matters: - Disposable medical devices sensors are becoming a core part of patient monitoring, diagnostics and infection control. - The market’s growth reflects rising demand for lower-risk, single-use tools that can support chronic disease management and remote care. - The category is positioned to benefit as healthcare systems push more monitoring into homes, clinics and telehealth workflows.

What happened: - The Business Research Company released its Disposable Medical Devices Sensors Global Market Report 2026, covering market size, trends and forecasts through 2035. - The market was valued at $9.65 billion in 2025 and is projected to rise to $10.74 billion in 2026. - The market is forecast to reach $16.42 billion by 2030, implying an 11.2% CAGR from 2026 to 2030. - The report said North America held the largest market share in 2025. - The Asia-Pacific region is expected to be the fastest-growing market during the forecast period.

The details: - Disposable medical devices sensors are single-use portable components used for diagnostics and patient monitoring. - The sensors provide rapid or one-time measurements of vital signs while maintaining sterility and reducing hygiene risks. - Historical growth has been supported by point-of-care testing, infection prevention in hospitals, wider adoption of wearable medical sensors, chronic disease monitoring and lower-cost sensor technologies. - Forecast growth is tied to demand for home healthcare monitoring, connected medical device investment, telehealth expansion, personalized medicine and wider use of disposable diagnostic tools. - Emerging trends include single-use sensor technologies, remote patient monitoring devices, disposable biosensors, point-of-care diagnostics and stronger infection control measures. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - The 2026 report package adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, plus updated graphics and tables. - The company offered a free sample and the full report through the sample report and the full market report.

Between the lines: - The market’s biggest near-term tailwind is chronic disease prevalence, which increases the need for low-friction monitoring tools. - A CDC report cited by the release said 76.4% of U.S. adults, or 194 million people, had at least one chronic condition in 2023. - The CDC data also showed prevalence rates of 59.5% for young adults, 78.4% for midlife adults and 93.0% for older adults. - North America’s lead suggests mature healthcare spending and faster adoption of advanced monitoring tools. - Faster growth in Asia-Pacific points to expanding access and broader technology adoption across the region.

What's next: - The market is expected to keep expanding as home monitoring, telehealth and connected devices gain more traction. - Disposable biosensors and remote monitoring tools are likely to stay in focus as providers look for scalable, infection-conscious ways to track patients. - The forecast period through 2030 suggests continued competition around affordability, usability and integration with digital care platforms.

The bottom line: - Disposable medical devices sensors are moving from niche components to a broader healthcare necessity, with chronic disease monitoring and home care driving the next leg of growth.